These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18329122)

  • 1. Recombinant human gelatin nanoparticles as a protein drug carrier.
    Won YW; Kim YH
    J Control Release; 2008 Apr; 127(2):154-61. PubMed ID: 18329122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
    Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
    Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
    Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
    Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
    Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levofloxacin and pefloxacin on humoral immune response elicited by bovine serum albumin docked in gelatin microparticles and nanoparticles.
    Madan J; Kaushik D; Sardana S; Ali A; Sudhakaran Sudheesh M; Shankar Pandey R
    Pharmazie; 2010 Apr; 65(4):284-9. PubMed ID: 20432626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of novel quaternized cellulose nanoparticles as protein carriers.
    Song Y; Zhou J; Li Q; Guo Y; Zhang L
    Macromol Biosci; 2009 Sep; 9(9):857-63. PubMed ID: 19370752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery.
    Xu Y; Jin X; Ping Q; Cheng J; Sun M; Cao F; You W; Yuan D
    J Control Release; 2010 Sep; 146(3):299-308. PubMed ID: 20580913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
    Shu S; Zhang X; Teng D; Wang Z; Li C
    Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles.
    Nahar M; Mishra D; Dubey V; Jain NK
    Nanomedicine; 2008 Sep; 4(3):252-61. PubMed ID: 18502187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method.
    Li JK; Wang N; Wu XS
    J Microencapsul; 1998; 15(2):163-72. PubMed ID: 9532522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular compartment targeting of layered double hydroxide nanoparticles.
    Xu ZP; Niebert M; Porazik K; Walker TL; Cooper HM; Middelberg AP; Gray PP; Bartlett PF; Lu GQ
    J Control Release; 2008 Aug; 130(1):86-94. PubMed ID: 18614254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano self-assembly of recombinant human gelatin conjugated with α-tocopheryl succinate for Hsp90 inhibitor, 17-AAG, delivery.
    Won YW; Yoon SM; Sonn CH; Lee KM; Kim YH
    ACS Nano; 2011 May; 5(5):3839-48. PubMed ID: 21517103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable, thermo-reversible and complex coacervate combination gels for protein drug delivery.
    Jin KM; Kim YH
    J Control Release; 2008 May; 127(3):249-56. PubMed ID: 18343521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
    Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
    Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
    Zhang J; Chen XG; Peng WB; Liu CS
    Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
    Balthasar S; Michaelis K; Dinauer N; von Briesen H; Kreuter J; Langer K
    Biomaterials; 2005 May; 26(15):2723-32. PubMed ID: 15585276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J; Chen XG; Li YY; Liu CS
    Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of protein release from photocrosslinked networks by gelatin microparticles.
    Weiner AA; Moore MC; Walker AH; Shastri VP
    Int J Pharm; 2008 Aug; 360(1-2):107-14. PubMed ID: 18565702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K; Winter G; Fricker G; Coester C
    Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.